Article
Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries
Registro en:
PETTIT, April C. et al. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. Journal of the International AIDS Society, v. 22, n. 12, p. e25423, 2019.
1758-2652
10.1002/jia2.25423
Autor
Pettit, April C
Jenkins, Cathy A
Blevins Peratikos, Meridith
Yotebieng, Marcel
Diero, Lameck
Do, Cuong D
Ross, Jeremy
Santos, Valdiléa Gonçalves Veloso dos
Hawerlander, Denise
Marcy, Olivier
Shepherd, Bryan E
Fenner, Lukas
Sterling, Timothy R
International Epidemiology Databases to Evaluate AIDS (IeDEA) Consortium
Resumen
The International Epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration is an international research consortium established in 2006 by the National Institute of Allergy and Infectious Diseases to provide a rich resource for globally diverse HIV/AIDS data. National Institutes of Health (NIH)./ President’s Emergency Plan for AIDS Relief (PEPFAR)./ United States Agency for International Development (USAID). Identification of persons living with human immunodeficiency virus (HIV)-associated tuberculosis (TB) at increased risk for unfavourable TB outcomes would inform efforts to improve such outcomes. We sought to identify factors associated with a decreased risk of unfavourable TB treatment outcomes among people living with HIV-infection (PLHIV) in low- and middle-income countries (LMIC), with a specific focus on directly observed therapy (DOT) compared with self-administered therapy (SAT) during the continuation phase of anti-TB therapy.